We are live on ! Find out more
Mirae Asset Global Investments

Mirae Asset Global Investments Portfolio holdings

AUM $67.7B
1-Year Est. Return 57.61%
This Fund
S&P 500
This Quarter Est. Return
+11.33%
1 Year Est. Return
+57.61%
3 Year Est. Return
+150.9%
5 Year Est. Return
+201.56%
10 Year Est. Return
+1,018.7%
AUM
$31.9B
AUM Growth
+$3.19B
Cap. Flow
+$655M
Cap. Flow %
2.06%
Top 10 Hldgs %
37.2%
Holding
1,711
New
132
Increased
1,102
Reduced
353
Closed
69

Sector Composition

Rank Sector Weight
1 Technology 36.43%
2 Communication Services 10.67%
3 Consumer Discretionary 9.33%
4 Healthcare 6.07%
5 Financials 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LYEL icon
1551
Lyell Immunopharma
LYEL
$347M
$12.1K ﹤0.01%
743
+173
+30% +$1.98K
EDIT icon
1552
Editas Medicine
EDIT
$436M
$12.1K ﹤0.01%
3,476
+242
+7% +$675
LMND icon
1553
Lemonade
LMND
$4B
$11.8K ﹤0.01%
221
-14
-6% -$683
H icon
1554
Hyatt Hotels
H
$16.8B
$11.8K ﹤0.01%
83
+63
+315% +$9.03K
ALX
1555
Alexander's
ALX
$1.39B
$11.7K ﹤0.01%
50
+2
+4% +$470
SCPH
1556
DELISTED
scPharmaceuticals
SCPH
$11.7K ﹤0.01%
2,061
+22
+1% +$113
WSR
1557
DELISTED
Whitestone REIT
WSR
$11.6K ﹤0.01%
948
+52
+6% +$655
KVHI icon
1558
KVH Industries
KVHI
$142M
$11.6K ﹤0.01%
+2,073
New +$11.5K
ALEC icon
1559
Alector
ALEC
$240M
$11.6K ﹤0.01%
3,913
+50
+1% +$110
CAN
1560
Canaan Creative
CAN
$154M
$11.5K ﹤0.01%
+13,023
New +$9.88K
VNDA icon
1561
Vanda Pharmaceuticals
VNDA
$314M
$11.4K ﹤0.01%
2,284
+7
+0.3% +$32
NMRA icon
1562
Neumora Therapeutics
NMRA
$317M
$11.4K ﹤0.01%
6,261
+13
+0.2% +$21
TECX
1563
Tectonic Therapeutic
TECX
$720M
$11.3K ﹤0.01%
723
+2
+0.3% +$41
UHT
1564
Universal Health Realty Income Trust
UHT
$573M
$11.3K ﹤0.01%
288
+15
+5% +$604
ACIU icon
1565
AC Immune
ACIU
$267M
$11.2K ﹤0.01%
3,882
+3
+0.1% +$7
OMER icon
1566
Omeros
OMER
$992M
$10.8K ﹤0.01%
2,631
+368
+16% +$1.46K
UHAL.B icon
1567
U-Haul Holding Co Series N
UHAL.B
$12.7B
$10.7K ﹤0.01%
210
-275
-57% -$14.6K
LRMR icon
1568
Larimar Therapeutics
LRMR
$454M
$10.7K ﹤0.01%
3,309
+836
+34% +$3.13K
FHTX icon
1569
Foghorn Therapeutics
FHTX
$394M
$10.7K ﹤0.01%
2,185
+32
+1% +$170
HUMA icon
1570
Humacyte
HUMA
$179M
$10.7K ﹤0.01%
6,123
+131
+2% +$257
ALLO icon
1571
Allogene Therapeutics
ALLO
$714M
$10.6K ﹤0.01%
8,578
+128
+2% +$153
FPI
1572
Farmland Partners
FPI
$425M
$10.4K ﹤0.01%
958
+53
+6% +$580
CBL
1573
CBL Properties
CBL
$1.77B
$10.4K ﹤0.01%
339
+19
+6% +$553
RNAC icon
1574
Cartesian Therapeutics
RNAC
$263M
$10.3K ﹤0.01%
1,005
-3,713
-79% -$41.7K
KYTX icon
1575
Kyverna Therapeutics
KYTX
$489M
$10K ﹤0.01%
1,672
+2
+0.1% +$8

Similar funds

Mirae Asset Global Investments's Q3 2025 Portfolio in Review

As of Q3 2025, Mirae Asset Global Investments held 1,711 positions worth $31.9B, up 11% from $28.7B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Mirae Asset Global Investments's Q3 2025 filing shows 132 new, 1,102 increased, 353 reduced and 69 closed positions. Its largest new stake was Invesco S&P 500 Momentum ETF: 537,274 shares worth $65M. The largest sale was Vanguard S&P 500 ETF, an estimated $453M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 35% a quarter earlier, followed by Communication Services and Consumer Discretionary.

  • Mirae Asset Global Investments's largest Q3 2025 buy was Invesco S&P 500 Momentum ETF: 537,274 shares worth $65M.
  • Mirae Asset Global Investments added most to NVIDIA in Q3 2025, an estimated $81.9M increase.
  • Mirae Asset Global Investments's biggest Q3 2025 reduction was Vanguard S&P 500 ETF, cutting an estimated $453M.
  • Mirae Asset Global Investments fully exited iShares S&P 100 ETF in Q3 2025, selling an estimated $58.9M.
  • Mirae Asset Global Investments's ten largest holdings make up 37% of its $31.9B portfolio in Q3 2025.
  • Mirae Asset Global Investments opened 132 new positions and closed 69 in Q3 2025.
  • Mirae Asset Global Investments's portfolio value rose 11% quarter-over-quarter to $31.9B.

Based on Mirae Asset Global Investments's 13F filing for Q3 2025, filed 3 Nov 2025.